Proportions of patients meeting definitions for progressive disease or improvement should be included in clinical trials for systemic sclerosis interstitial lung disease
Related Posts
Yen EY, Park EJ, Singh RR. Lupus, a Leading Cause of Years of Potential Life Lost in Young Women: Implications for Public Health Priorities and[...]
Brauer ER, Choi KR, Petersen L, Ganz PA, St John MA, Wong DJ, Martin EJ. Social wellbeing, loneliness, and symptom burden in head and neck[...]
Mosher CL, Casaburi R. Pulmonary Rehabilitation Prolongs Life…And May Be Dying. Am J Respir Crit Care Med. 2026 Apr 7:aamag168. doi: 10.1093/ajrccm/aamag168. Epub ahead of[...]